Renal filtration, transport, and metabolism of low-molecular-weight proteins: A review  by Maack, Thomas et al.
Kidney International, Vol. 16 (1979), pp. 251-2 70
Renal filtration, transport, and metabolism of low-molecular-
weight proteins: A review
THOMAS MAACK, VALERIE JOHNSON, SEN T. KAU, JOSE FIGuEIRED0, and
DANIEL SIGULEM
Department of Physiology, Cornell University Medical College, New York, New York
Low-molecular-weight proteins are a hetero-
genous group of substances which constitute a
small but biologically important fraction of total cir-
culating proteins. The group comprises enzymes
(for example, ribonuclease, lysozyme), immuno-
proteins (for example, light chains of immunoglobu-
lins, 132 microglobulin), and peptide-hormones (for
example, insulin, growth hormone, parathyroid
hormone). Despite general recognition that the kid-
neys play an important role in the plasma turnover
and in the maintenance of adequate plasma levels of
small proteins, the study of the renal handling of
these substances still constitutes one of the most
underdeveloped areas of research in renal physiolo-
gy. Nevertheless, recent advances in the field have
been considerable and are the subject of the present
review. Without attempting to be all inclusive, we
will analyze the evidence regarding the extent,
pathways, and mechanisms of the renal accumula-
tion, filtration, absorption, and metabolism of small
proteins. A final section will then deal with the renal
turnover and the homeostatic role of the kidney in
the maintenance of adequate plasma levels of these
substances. A critical appraisal of the methods used
to estimate glomerular sieving coefficients and renal
turnover rates of small proteins will be given in
some detail, because a correct determination of
these parameters is essential to an understanding of
the kidney's role in the disposal of circulating small
proteins.
Some aspects of the renal handling of small pro-
teins are common to all members of the group, for
example, filtration, absorption, intracellular catabo-
lism. Other aspects are probably specific for partic-
ular proteins, for example, interaction with recep-
tors at the peritubular side. We will emphasize the
former and only mention the latter briefly. The
reader should be aware, however, that the hetero-
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geneity of the group, both in molecular structure
and biologic function, makes it likely that some pro-
teins may be processed by the kidney by modes not
encompassed in the generalized picture described in
the present review.
I. Renal accumulation of administered small proteins
The initial suggestion that the kidneys play an im-
portant role in the disposal of circulating small pro-
teins derives from data on the organ distribution of
administered labeled or unlabeled enzymes and
peptide hormones. Results of studies conducted
from the early 50's to the present in intact animals
and in the isolated perfused rat kidney with a host of
small proteins (for example, insulin [INS], glucagon
[GLU], ACTH, growth hormone [GH], PTH, fol-
licle-stimulating hormone [FSH], luteinizing hor-
mone [LH], ribonuclease [RNAase], and lysozyme
[LZM]) demonstrate that 20 to 50% of the adminis-
tered dose is distributed in the kidney [1—16]. The
degree of renal uptake is related grosso modo to the
molecular size of the protein. For example, in the
flounder the renal volume of distribution ( space")
of administered egg-white LZM (14,000 daltons) is
at least two orders of magnitude greater than that of
horseradish peroxidase (HP; 40,000 daltons) [7,
12, 17]. This inverse relationship between molecu-
lar size of the protein and degree of renal accumula-
tion is to be expected if the process is primarily de-
pendent on glomerular filtration of the protein.
The site of accumulation within kidney tissue has
been shown by several investigators using autora-
diographic and histochemical techniques to reside
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mainly, if not exclusively, in proximal tubular cells
[8, 10, 13, 18—23]. As observed with larger proteins
[24, 25], absorbed small proteins were mainly local-
ized in endocytotic vesicles in the apical regions of
the cell shortly after administration of the protein
and in secondary lysosomes (phagolysosomes)
thereafter [25—29]. In differential centrifugation
studies on the localization of administered LZM
and HP, part of the absorbed protein was found in
the cytosol in an amount exceeding that expected
from the disruption of lysosomes during the ultra-
centrifugation procedure [10, 21]. It is possible
that the cytosolic localization of these proteins is
the result of in vivo disruption of lysosomes caused
by the concentration of a poorly hydrolyzable pro-
tein within these cell organelles. The subject of
cytosolic localization of absorbed proteins, how-
ever, is controversial, and a detailed discussion of
this point is beyond the scope of this article (see
Refs. 10, 12, 28). Mitochondrial localization of ad-
ministered 1251-labeled bovine PTH has been report-
ed [30]. By the time the animals were sacrificed af-
ter the administration of '251-labeled bovine PTH,
however, it is probable that most of the hormone
had already been hydrolyzed [16], and the auto-
radiographs most likely detected labeled catabolic
products rather than the intact hormone.
The apical localization of protein in proximal
tubular cells early after protein administration sug-
gests that renal accumulation of small proteins pro-
ceeds via ifitration and subsequent tubular uptake
of the filtered proteins. However, accumulation via
leakage from peritubular capillaries and subsequent
uptake or absorption at the basal side of the cell has
also been postulated. Definitive proof that the filtra-
tion-luminal absorption pathway is the major if not
the exclusive route for renal uptake of small pro-
teins has been obtained recently in experiments
with '25I-labeled rat LZM, rat GH, bovine PTH, and
INS in the isolated perfused rat kidney [11—16]. Fig-
ure 1 summarizes the results of these experiments.
When the proteins were added to the perfusate of a
normal perfused kidney, extensive renal accumula-
tion occurred, resulting in protein renal tissue to
perfusate concentration ratios above 3.0 as com-
pared to 0.3 for an extracellular volume marker.
When tubular absorption of protein was inhibited
by adding cyanide or iodoacetate to the perfusate
(see tubular absorption section) while GFR and
RPF were maintained at control levels, tissue accu-
mulations of all four proteins fell dramatically to
concentrations close to those of the extracellular
volume marker. Similar dramatic decreases oc-
curred for '251-labeled rat GH and bovine PTH when
the perfused kidney was rendered a nonfiltering pre-
paration, while RPF was maintained at control lev-
els. The latter manuever was accomplished by rais-
ing the oncotic pressure of the perfusate to levels
sufficient to counterbalance the filtration pressure.
Under these conditions, GFR practically ceases,
whereas the uptake of organic acids from the pen-
tubular side remains unaffected [31]. These experi-
ments provide definitive proof that the filtration-
liminal uptake route is the predominant pathway for
renal accumulation of the four proteins studied.
They do not exclude, however, the possibility that
some of these proteins may interact with receptors
and be modified at peritubular sites (for example,
INS, PTH, see section IV).
There has been justified caution in interpreting
the results described above as proof or even in-
dication that the kidney is an important organ for
the disposal of endogenous circulating small pro-
teins. First, in several of the experiments, heterolo-
gous or foreign proteins were used, and it is not cer-
tain that the disposal of these proteins is equivalent
to that of endogenous proteins. Second, in several
instances labeling of proteins with I or 1251 may
have resulted in denaturation, or loss of biological
activity of the molecule, or both. This in turn could
have altered the plasma turnover, or the renal han-
dling of the labeled proteins, or both. Third, mea-
surement of total radioactivity, or even tn-
chloracetic-acid-precipitable radioactivity, in kid-
J Control
KCN0rIAA
Nonfiltering
10
8
a,
>- 'a
V
4
'-a
0
2
125J-ratLZM 12511 NS 1251-ratGH 1251-bovinePTH
Fig. 1. Tissue-f o-perfusate ratio of radioactivity in isolated rat
kidneys during perfusion with radioiodinated proteins, in control
filtering kidneys, in kidneys perfused with iodoacetate (IAA, 10
,nat) and in nonfiltering kidneys. The GFR and renal perfusate
flow (RPF) of IAA treated kidneys were not significantly dif-
ferent from that of control kidneys. In the nonfiltering kidney,
GFR was negligible, and RPF was similar to that of the control
filtering kidneys (see text). Tissue-to-perfusate ratio of '4C-po-
lyethylene glycol or '4C-inulin in the nonfiltering kidney was about
0.3. Data is from Refs. 11, 12, 14—16, 39.
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ney tissue after administration of labeled proteins
does not necessarily differentiate between a labeled
protein or labeled catabolites of the protein. Despite
these limitations, there is strong evidence that stud-
ies on the renal accumulation of administered la-
beled proteins provide a useful indicator of the im-
portance of the kidney in the disposal of their en-
dogenous counterparts. This evidence can be
summarized as follows:
(1) In the rat, renal accumulation of administered
125I-labeled or unlabeled egg-white LZM does not
differ markedly from that of labeled or unlabeled rat
LZM [9, 11]. In the case of GH, renal accumulation
of 1251-labeled rat GB in the intact rat or in the iso-
lated rat kidney was only slightly greater than
that of '251-labeled human GH [13, 15]. Thus, at
least for the proteins studied, the renal accumula-
tion of heterologous forms do not differ greatly from
that of their homologous counterparts.
(2) Denaturation and loss of biologic activity up-
on labeling with iodine is a serious problem, be-
cause it is extremely difficult to determine the bio-
logic activity of the labeled molecules. Bowever,
mildly iodinated '251-labeled rat GB (less than 1 io-
dine atom per molecule protein), which retained its
integrity, as attested by radioreceptor and radioim-
munoassay, was accumulated extensively in kidney
tissue [15]. Thus, it is likely that mildly iodinated
proteins behave as the native molecule with regard
to renal accumulation. Loss of biologic activity it-
self apparently does not affect the degree of renal
uptake of a protein. Thus, the degree of accumula-
tion of biologically inactive 1251-labeled bovine PTB
was found to be similar to that of a biologically ac-
tive tritiated bovine PTH [8, 23]. It should be kept
in mind, however, that strong iodination may lead
to formation of labeled protein aggregates which,
because of their large size, will result in a reduction
in the renal uptake of labeled proteins [13, 15].
(3) Finally, in the cases of '251-labeled LZM, rat
GH, and human GB, it was shown by chromato-
graphic techniques that the label accumulated in
kidney was attached to a molecule that eluted in the
same region as the parent protein molecule [10, 13,
15]. Furthermore, the isolated perfused rat kidney
accumulated these proteins to the same extent as
did the intact rat, demonstrating that the radio-
activity present in kidney could not have originated
from catabolism of the protein in other organs with
subsequent uptake of labeled catabolites by the
kidney [11—16].
The data on the renal accumulation of adminis-
tered proteins described so far indicates the impor-
tance of the filtration process as the initial step for
the renal processing of small proteins. The quan-
titative aspects of the filtration of proteins will be
considered in the next section.
II. Renalfiltration of small proteins
Proteins are hindered at the glomerular filter in
proportion to their molecular size, structure, and
net charge. Factors which influence the filtration of
macromolecules have been extensively reviewed
before, and a full discussion of glomerular permse-
lectivity is beyond the scope of the present article
(see Refs. 32, 33). Unfortunately, the multifactorial
influence of dimension (Stokes-Einstein radius)
charges and the quaternary structure (asymmetry
and rigidity of the molecular skeleton) is such that
glomerular sieving curves obtained with artificial,
charged or uncharged polymers and selected pro-
teins cannot yet be used to estimate the glomerular
sieving coefficient (GSC) of any one particular pro-
tein. Since the methods used to determine GSC's
are difficult and sometimes marred by experimental
and interpretative shortcomings, there are only a
few small proteins for which the GSC is known with
any degree of confidence. As will be seen later,
however, the degree of filtration is the rate-limiting
step for the plasma disappearance rate (metabolic
clearance rate) of several small proteins. Therefore,
a correct estimate of the GSC is of paramount im-
portance to elucidate the mode and extent by which
small circulating enzymes, immunoproteins, and
protein-hormones are handled by the kidney.
Because direct measurement of small protein
concentration in the glomerular filtrate has not yet
been proven possible,' several indirect approaches
1 Lack of reported direct measurements of concentration of
small proteins in the filtrate may be surprising at a first view,
particularly if one considers the relatively large number of re-
ported determinations of the concentration of albumin and total
proteins in the glomerular filtrate. The technical difficulties, how-
ever, are multiple: (1) enzymatic or biologic assays are not sensi-
tive enough to detect any particular small protein in nanoliter
samples of filtrate; (2) radioimmunoassays may be sensitive
enough, but have the drawback, not only of cross reactivity be-
tween different protein species, but also, and most importantly,
of the inability to discriminate between different forms of the
same hormone, as is well illustrated in the case of PTH and
GLU; (3) use of radioiodinated proteins may prove useful.
Strong labeling procedures, however, which are used to obtain
the requisite specific activities, may polymerize the protein
molecule and give false values for its GSC. Even if polymeriza-
tion could be avoided, it would be difficult to separate in gb-
merular filtrate samples the intact labeled molecule from labeled
catabolites that may originate from the metabolism of protein in
other organs; (4) finally, it is always difficult to solve the prob-
lems of binding of the protein to the glass of micropipettes used
to sample the glomerular filtrate.
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Table 1. Glomerular sieving coefficients of small proteins
Protein
Mol wt
daltons
Stokes-Einstein radiusa
A Glomerular sieving coefficient
Insulin 6,000 (<16.4) 0.89 Method 2b isolated rat kidney [14]
Lysozyme 14,600 19.0 0.75 Method 1, dog [11,36,37]
0.75 Method 2, isolated rat kidney [12, 39]
0.75 Method 5, isolated rat kidney [12]
Myoglobin 16,900 18.8 0.75 Method 1, dog [51]
Bovine PTH 9,000 (—21 .4)' 0.66 Method 2, isolated rat kidney [16]
0.64 Method 3, isolated rat kidney [16]
0.77 Method 3, dog [41]d
Rat GH 20,000 (20.4) 0.72 Method 2, isolated rat kidney [15]
0.58 Method 3, isolated rat kidney [15]
Horseradish peroxidases 40,000 31.8
29.8
30.0
0.007 (anionic)1
0.06 (neutral) Method 5, rat [45]
0.34 (cationic) J
Bence Jones (X-L chain) 44,000 27.7 0.09 Method 1,dog [38]
0.08 Method 4,mouse [43]
a Values were obtained or calculated (number in parenthesis) as in Ref. 31 (legend to Table 2, p. 188) except for horseradish per-
oxidases, which were obtained from Ref. 45.
b The indirect methods for obtaining the glomerular sieving coefficients are described fully in the text. The number in the table
corresponds to the number of the method in the text.
a At plasma pH, bovine PTH behaves as an approximately 22,000-dalton globular protein (Ref. 46 and text).
d This was calculated from data given in Ref. 41 for kidneys with a normal GFR (see Ref. 16 and text).
have been used to estimate the GSC for small pro-
teins. Table 1 summarizes values for the GSC of
several small proteins obtained by different meth-
ods. A description and a critical appraisal of these
methods follow below:
Method 1: Fractional clearance of proteins. The
simplest of the indirect methods is the determina-
tion of the protein clearance (as a fraction of the
GFR) at high plasma concentrations of the protein.
The high plasma concentrations are necessary to
minimize the decrease in urinary excretion rates
due to tubular absorption of proteins. Unfortu-
nately, the extent, as well as the kinetic character-
istics, of the tubular absorption process is such that
results obtained with this method must be inter-
preted cautiously. Thus, many authors have as-
sumed that a linear relationship between urinary ex-
cretion and plasma concentration of a particular
protein is indicative of saturation of tubular absorp-
tion [34—36]. A similar linear relationship is ob-
tained, however, at high plasma concentrations of
proteins if their fractional absorption is constant
over a wide range of filtered loads, as was clearly
shown to be the case for LZM [11, 12] (see section
on "tubular absorption"). As a result, earlier deter-
minations of the GSC of LZM [34, 36] gave values
which were much lower (0.2 to 0.5) than the values
obtained in more recent determinations (0.7 to 0.8)
in which tubular absorptive capacity for LZM had
indeed been exceeded [11, 37]. Studies with other
proteins such as GH, PTH, and INS also provided
evidence that linearity between urinary excretion
and plasma concentration is not proof that the tubu-
lar maximum (Tm) for absorption of these proteins
was exceeded (see section on "tubular absorp-
tion"). The high plasma concentrations of small
proteins necessary to obtain reliable estimates of
the GSC by the fractional clearance method may
however introduce other artifacts. For example,
GFR or permselectivity of the glomerular barrier
may be altered by high plasma concentrations of
proteins. A case in point is the observation that high
plasma concentrations of egg-white LZM in the dog
may produce, on some occasions, sudden falls in ar-
terial pressure [36] (Maack, unpublished observa-
tions). Despite these drawbacks, the fractional
clearance method, if judiciously used, may provide
reliable values for the sieving coefficient of small
proteins. Thus, the method provided estimates for
the sieving coefficient of LZM of 0.7 to 0.8 [11, 37,
38] and for Bence Jones protein of 0.09 [39], values
similar to those obtained by some of the methods
described below.
Method 2: Fractional clearance of proteins in the
absence of tubular absorption. The finding that
tubular absorption of protein can be almost com-
pletely blocked by metabolic inhibitors such as cy-
anide or iodoacetate made it possible to determine
the GSC of small proteins at normal plasma concen-
trations [11—16, 40]. In this approach, the fractional
clearance of the small protein is measured in the
presence of high concentrations of iodoacetate or cy-
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Table 2. Fractional clearance and urine : perfusate ratios of small proteins in control isolated perfused rat kidneys and in isolated kidneys
perfused with 10 mr.i iodoacetate or 3 mai cyanide b
Protein
Control Experimental
(UIP)GM (U/P) CnJGFR (U/P)GM (U/P),, C.,./GFR Ref.
'251-rat LZM
Egg-white LZM
1251-INS
1251-ratGH
1251-bovinePTH
15.8
16.1 1.2
23.8 1.0
33.4 0.3
1.4
1.2 0.3
0.2 0.05
0.50 0.11
0.09
0.26
0.07
0.02
0.02
0.05
0.02
0.001
0.001
1.01
0.98
1.2
1.2
0.05
0.1
0.02
0.84
0.84 0.05
0.91 0.04
0.79 0.03
0.83
0.77 0.06
0.08 0.03
0.86 0.06
0.72 0.03
0.66 0.001
[11,37]
[121
[12, 39]
[14]
[15]
[16]
For details of procedure consult the listed reference.
b Values are mean 5EM of at least four experiments, except those for 1251-rat LZM which are from a single experiment.
U/P is urine perfusate ratio; GM is glomerular marker (creatinine, 14C-inulin, or '4C-polyethyleneglycol); Pr is protein.
anide. This method circumvents the influence of
tubular absorption and thus avoids the drawbacks
of method 1. Two limitations to this method, how-
ever, must be considered. First, it cannot be used in
intact animals because of the high concentrations of
inhibitors needed to abolish completely tubular ab-
sorption of proteins. Second, the inhibitors increase
slightly (15 to 20%) but significantly the glomerular
permeability to neutral dextrans of mean molecular
weights of 20,000 daltons [15] and hence should not
be used to determine the GSC of proteins larger
than this size. Table 2 lists the GSC's of LZM,
PTH, GH, and INS obtained by this method in an
isolated perfused rat kidney preparation with near-
normal function and normal glomerular per-
meability to neutral dextrans (for details of the
preparation and function of the isolated perfused rat
kidney, consult Refs. 15, 16, 41). The high value for
the GSC of INS (0.9) obtained by this method is
expected for a 6,000-dalton protein and is the only
value thus far reported in the literature. The values
for the GSC of LZM (0.7 to 0.8) and PTH (0.65)
were in good agreement with those obtained with
method 3. The GSC of rat GH (the larger of these
proteins; mol wt, 20,000 daltons) was, however,
about 20% larger than that determined by method 3
(see Table 1). A still greater discrepancy was ob-
served when the GSC for a 1251-labeled human GH
preparation containing a mixture of 20,000-mol-wt
and larger aggregates was measured by both meth-
ods (0.5 with method 2, 0.39 with method 3 [13,
15]). Therefore, it is apparent that method 2 is valid
for the determination of the GSC of proteins smaller
than 20,000 daltons but becomes less reliable as the
size of the protein increases. This is not surprising,
since it is to be expected that changes in glomerular
permselectivity will affect predominantly the GSC
of proteins with sizes closer to that of the filtration
"pores" (see Section III).
Method 3: Fractional extraction method. In our
view, this is the most reliable method for the in-
direct determination of the GSC of those small pro-
teins which are extracted by the kidney solely by
filtration. The method is based on the theoretical
principle that for a protein which is extracted by fil-
tration alone, the ratio of its renal extraction rate to
the renal extraction rate of a glomerular marker
(that is, the GFR) measures the concentration of the
protein in the glomerular filtrate, relative to plasma.
An independent proof that the protein is not appre-
ciably extracted from the peritubular side (as com-
pared to extraction by filtration) and that the protein
is not reabsorbed intact from lumen to blood must
be provided to validate the method. The GSC of
1251-labeled rat GH and '251-labeled bovine PTH de-
termined in the isolated perfused rat kidney by this
method gave mean values of 0.58 and 0.64, respec-
tively [15, 16]. From data of experiments reported
in the literature in which renal extraction of immu-
noreactive bovine FF11 and creatinine were simul-
taneously measured in the dog [42], it is possible to
calculate that the GSC of bovine PTH in the dog
was 0.77 0.07, a value not significantly different
from that of the GSC for 1251-labeled bovine FFH
(0.64 0.07) in the isolated rat kidney [16]. Calcu-
lated values for the GSC of sheep GH in the sheep,
with this method, were between 0.3 and 0.4 [43].
Because the administered sheep GH contained an
unknown mixture of monomers and dimers of the
hormone, it becomes difficult to interpret this re-
sult.
A great advantage of method 3 is that no extra-
neous experimental interventions, such as the use
of inhibitors or high plasma protein concentrations,
are needed. In principle, method 3 can be used to
measure the GSC of small endogenous circulating
proteins without the need of administering the pro-
tein to the experimental animal. Unfortunately, it
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tion rate of the protein in the course of the experi-
ment, and DT is the amount of filtered protein ca-
tabolized in renal tissue in the course of the experi-
ment. For proteins which are slowly catabolized by
renal tissue, such as LZM and HP, DT is negli-
gible, and determination of their GSC becomes
simple because T, UprV, GFR, and Pp can be eas-
ily measured. Values of GSC of LZM obtained by
this method in the isolated perfused rat kidney were
not significantly different from those obtained with
method 2 in the same preparation and with method
1 in the intact dog [12]. Very recently, this method
has been successfully applied to a determination of
the differences between the GSC's of anionic, cat-
ionic, and neutral horseradish peroxidases of the
same molecular size [46].
When the renal catabolism of the absorbed pro-
tein in the course of the experiment is significant, as
is the case with most peptide hormones, DT has to
be determined independently. There is no available
method to do this in intact animals. In the isolated
perfused kidney, the renal catabolic rate of a pro-
tein can be determined by measuring the rate of ef-
flux of catabolites from kidney tissue to the per-
fusate [15, 16]. The USC of 1251-labeled rat GH in
the isolated rat kidney computed by this method
(with a value for DT derived from results of effiux
experiments) was 0.62, a value not significantly dif-
ferent from that obtained using method 3 (0.58; see
above and Ref. 15).
The great advantage of method 3 is its simplicity,
particularly when used for proteins which are ca-
tabolized very slowly by the kidney. Its main limita-
tions are that it cannot be used for proteins that are
taken up from the peritubular side, and steady state
conditions must be assured (that is, UV, and
GFR should remain relatively constant in the
course of the experiment). Otherwise Equation 1
loses its validity.
All methods described above are indirect, and
therefore the results obtained should be interpreted
cautiously. As a rule, confidence in the reliability of
the esimates for the USC of a protein are greatly
increased when independent determinations by two
or more of these methods agree closely. Despite the
limitations of the methods used to determine the
USC of protein, the following general conclusions
(1) regarding the filtration of small proteins can be
drawn from the data obtained so far:
(1) Proteins smaller than 25,000 daltons (23 A)
cross the glomerular barrier, attaining concentra-
tions in the glomerular filtrate that are usually more
than 50% of their concentrations in plasma. Consid-
cannot be used for all small proteins since some of
them (for example, INS) are probably extensively
extracted from the peritubular side (see section V).
Method 4: Fractional renal catabolic rate. This
method is a slightly more complex variant of meth-
od 3 and consists in determining the slope of the
regression line obtained by plotting the plasma dis-
appearance rate of a protein (measured as a fraction
of the intravascular pool cleared from plasma per
unit of time) against the clearance of creatinine (also
as a fraction of the intravascular pool cleared from
plasma per unit of time) [44]. The reader is referred
to the discussion of Ref. 44 for a detailed description
of this method. The GSC of X-L chain Bence Jones
protein (mol wt, 44,000 daltons) determined by this
method in mice gave values between 0.07 and 0.09,
in very good agreement with the USC values ob-
tained in the dog using method 1. Method 4 was also
used to determine the sieving coefficient of LZM in
humans and gave a mean value of 0.35 [45], which is
lower than estimates of the GSC of LZM by meth-
ods 1 and 2 in other species.
The same limitations described for method 3 (that
is, absence of significant peritubular extraction and
absence of transtubular transport of intact protein)
also apply to this variant. The disadvantage of
method 4 is the usual large error in measurements
of plasma-decay curves in intact animals. In our
view, however, this variant is of great value when
direct measurement of protein renal arteriovenous
differences is not feasible or is very difficult as in
small laboratory mammals or in humans.
Method 5: Renal tissue accumulation method.
This is a relatively simple method for estimating the
GSC of administered proteins that are accumulated
by the renal tissue. The method was first used to
test whether renal accumulation of lysozyme could
be accounted for by filtration alone [11, 12]. In this
method, the protein under study is infused in intact
animals or is added to the perfusates of isolated kid-
neys. Plasma concentration and urinary excretion
of the protein are measured in the course of the ex-
periment together with the GFR. At the end of the
experiment, the renal tissue content of the protein is
measured. The GSC of the protein is given by the
formula:
—
Tpr + UV + DTGSCPF — GFR X Pr
where is the amount of protein accumulated by
the renal tissue by the end of the experiment; PPr is
the plasma or perfusate protein concentration in the
course of the experiment, UV is the urinary excre-
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ering the magnitude of the GFR in mammals and the
usually short plasma half-life of most small pro-
teins, the filtration process accounts for a major
portion of the removal of circulating small pro-
teins from the vascular compartment (see Section
V).
(2) Apparently, molecular dimensions and mo-
lecular shape (rigidity) are the main determinants of
the degree of glomerular sieving of proteins smaller
than 25,000 daltons or 23 A. Below this size, net
charge of the protein molecule has less of an effect
than that observed for dextrans or proteins larger
than 25 A, such as albumin or horseradish per-
oxidase. Thus, the GSC of the anionic protein myo-
globin (19 A) is almost the same as the GSC of the
similarly sized but highly cationic lysozyme (see
Table 1). This finding does not contradict the criti-
cal importance of charge as a determinant of gb-
merular permselectivity of the larger proteins [33,
46]. It is reasonable to postulate that the closer the
size of the protein molecule to the size of the
"pores" of the glomerular filter, the larger will be the
electrical hindrance for the passage of that protein to
the filtrate. As previously postulated [32], the influ-
ence of symmetry and shape of the protein molecule
on the GSC's of proteins is a major one. Thus, bo-
vine PTH, a 9,000-dalton cationic protein, has only
a slightly higher GSC than does rat GH, a 20,000-
dalton anionic protein (Table 1). As previously
pointed out [16], this apparent discrepancy can be
explained by the high degree of asymmetry of the
bovine PTH molecule, as discovered in studies of
the elution characteristics of this protein on Sepha-
dex [47]. Thus, when bovine PTH is eulted on Seph-
adex at a pH close to that of plasma, it migrates as a
20,000-dalton globular protein. At a very alkaline pH
or in the presence of 6 M guanidine buffer (condi-
tions which tend to randomize protein coils and
hence decrease the degree of asymmetry of the
molecule) it elutes as a 9,000-dalton globular pro-
tein. Therefore, it is not surprising that bovine
PTH and rat GH have similar glomerular sieving co-
efficients [15, 16]. The influence of shape or rigidity
of the molecular structure also has been postulated
recently to explain the finding that horseradish per-
oxidases have a lower GSC than do dextrans of sim-
ilar size and charge [46].
(3) The degree of sieving of a protein is not de-
pendent on the biologic activity of the molecule it-
self. It is exclusively a function of the physical char-
acteristics of the molecule (size, charge, shape) and
those of the glomerular filter (GFR, permselectivi-
ty). Thus, the filtered load of a protein under normal
conditions is directly related to its plasma concen-
tration. As will be discussed in a later section (see
Section V), this relationship is of fundamental im-
portance to an understanding of the role of the kid-
ney in the overall plasma turnover of small proteins.
III. Tubular absorption and urinary excretion of small
proteins
The ability of the renal tubular epithelium, partic-
ularly that of the proximal tubular cells, to absorb
proteins and colloids has been known since the first
decades of this century [48, 51]. The process of re-
nal cell uptake and catabolism of filtered proteins
has fascinated cell biologists and renal pathologists
ever since, and a variety of elegant morphologic
studies have been performed to elucidate these phe-
nomena [21, 22, 24—26].
For the purpose of this article, it suffices to sum-
marize the major conclusions of these studies. It is
generally accepted that proteins are absorbed by
segregation into endocytotic vesicles at the apical
borders of the tubular cells. Apparently, this is an
exclusive property of the luminal cell membrane,
because there is no evidence for the presence of an
endocytotic apparatus on the basolateral membrane
of tubular cells. The endocytotic vesicles migrate
from the apical borders to the cell interior and even-
tually fuse with lysosomes. This as yet poorly un-
derstood process brings into contact the absorbed
protein and the hydrolytic enzymes present in these
cell organelles. After variable periods of time which
may last from minutes to days, depending on the
particular species of protein studied, the absorbed
protein is no longer detectable within the secondary
lysosomes. Results of intracellular localization
studies are consistent with the hypothesis that reab-
sorbed proteins are catabolized within the renal
cells.
The morphologic aspects of protein absorption
were the same whether the protein was injected into
the intact experimental animal or was infused di-
rectly into the lumen of perfused convoluted proxi-
mal tubules, in vivo or in vitro [25, 27, 29]. Dif-
ferential centrifugation studies confirmed in general
the morphologic findings described above [10, 22].
The endocytotic uptake and intracellular pathways
of protein absorption were first described for larger
foreign or heterologous proteins (albumin, hemo-
globin, horseradish peroxidase), but in the last dec-
ade it was shown that small proteins such as GH,
LZM, and INS are absorbed by the same process
[10, 27—29].
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Contrasted to the wealth of qualitative and mor-
phologic studies, there is a relative paucity of quan-
titative studies regarding the tubular absorption and
intracellular catabolism of filtered proteins. This is
primarily due to the difficulties in determining the
concentration of proteins in the giomerular filtrate,
without which it is not possible to quantitate the ab-
sorption process.
A classical approach to the estimation of tubular
absorption maximum (Tm) of a protein is to measure
its urinary excretion rates over a wide range of
plasma concentrations. For most proteins studied,
above a certain plasma concentration there is a lin-
ear relationship between urinary excretion and
plasma concentration. This is naturally similar to
that observed for glucose and other small organic
solutes at high plasma concentrations of these sub-
stances.
Based on this similarity, it has been postulated
that the ordinate intercept of the regression line be-
tween plasma concentration (abcissa) and urinary
excretion (ordinate) measures the maximum ab-
sorptive capacity (Tm) of that protein. The Tm of
larger proteins determined in this manner was not
significantly different from zero for some, such as
Bence Jones protein (X-L chain [33]) and free hemo-
globin [35] but it had a significant albeit variable val-
ue for albumin [35]. The reliability of these results
is, however, open to question. First, the fundamen-
tal assumption of this method is that a linear rela-
tionship between urinary excretion and plasma con-
centration of a protein demonstrates that the tubu-
lar absorption mechanism for that protein is
saturated. As will be described below, depending
on the range of plasma concentrations attained, it
is, however, possible to demonstrate such a linear
relationship while tubular absorption is not yet satu-
rated. Second, for larger proteins with very low gb-
merular sieving coefficients, small changes in gb-
merular permselectivity or GFR during the course
of the experiment may obscure or magnify the
degree of tubular absorption of these proteins.
This indirect approach has been used also to esti-
mate tubular absorption of smaller proteins, such as
myoglobin (mol wt, 17,500 daltons) [52]. The esti-
mated value for the Tm of myoglobin (approximate-
ly 3 mg/mm) appears low, but it should be kept in
mind that it is at least two orders of magnitude
above the normal filtered load of any particular cir-
culating endogenous protein smaller than 20,000
daltons.
True renal titration experiments (that is, experi-
ments in which urinary excretion or tubular absorp-
tion are plotted against filtered loads rather than
plasma concentration of the protein)• were per-
formed with egg-white LZM in the intact dog and in
an isolated perfused rat kidney preparation [11, 12,
37, 38]. The difference between these and the above
experiments is that the glomular sieving coefficient
of LZM had been determined with a certain degree
of confidence by several independent methods (see
Section II). Results of LZM renal titration experi-
ments in the dog revealed some previously unsus-
pected characteristics of the process of tubular ab-
sorption of proteins [11, 12, 37]. First, the Tm for
absorption in the dog was about 1.0 to 1.5 mg/mm, a
value 50 to 100 times larger than the normal filtered
load of endogenous lysozyme in the dog. Second,
despite this large absorptive capacity, urinary ex-
cretion of LZM started at filtered loads close to nor-
mal; that is, there was a large difference between
the threshold and the Tm of lysozyme. Third, within
the large range of filtered loads between threshold
and Tm, fractional absorption of LZM was relatively
constant, amounting to about 50% of the filtered
load of LZM. As a consequence, fractional LZM
clearance (CLZM/GFR) remained constant within this
range. Therefore, increases in LZM filtered loads,
above threshold and below Tm, led to a concomitant
increase in the tubular absorption and urinary ex-
cretion of the protein. Similar results were obtained
in the isolated perfused rat kidney, as shown in Fig.
2. Results of these experiments led to the con-
clusion that the LZM tubular absorption process is
best described as a high capacity (as compared to
normal filtered loads), low affinity transport process
[11, 12, 38]. -
Studies with rat GH in the isolated rat kidney [15]
and INS in the intact dog [53], or rat [54] also
showed that the absorptive capacity remained un-
saturated at filtered loads above normal for these
proteins. Whether this characteristic applies to other
small proteins as well remains to be determined.
In a few instances, tubular uptake of proteins was
measured by microperfusion techniques. In the pio-
neer work [54], 1311-labeled INS, RNAase, and albu-
min were microinfused into the tubular lumen of
rats in vivo. Tubular absorption was determined by
the difference between the amount infused and the
amount of TCA insoluble radioactivity recovered in
the urine. lodothalamate was infused together with
the proteins, and its recovery in urine was close to
100%. When proteins were infused at different
points along the proximal tubule, tubular absorption
varied depending on the site of infusion: 50 to 70%
of the dose of 1311-RNAase or 1311-INS was absorbed
when these proteins were infused in the early proxi-
mal tubule (first 20%). Absorption of proteins
beyond the convoluted proximal tubules was either
small or absent. Absorption of 1311-albumin was less
than that of 1311-RNAase or 1311-INS. Another inter-
esting finding of these experiments was that as in-
fused amounts of 1311-INS were increased 400-fold,
tubular absorption increased correspondingly, in-
dicating a constant fractional absorption of this pro-
tein along the proximal tubule. Tubular absorption
of 1251-INS was also detected in experiments in iso-
lated perfused convoluted tubules of the rabbit [27].
In the latter, the protein was added to the perfusion
fluid, and tubular uptake was determined by mea-
suring the radioacivity accumulated by the isolated
nephron. Recently, the tubular absorption of 125J..
labeled human GH in isolated perfused proximal tu-
bules of the rabbit was determined (Figueiredo and
Maack, unpublished results). Figure 3 shows the re-
sults, and the legend gives a summary of the meth-
odology used in this study. The results show that
convoluted proximal tubules of the rabbit remove
1251-labeled human GH from tubular lumen at a rate
of about 50% of the load per millimeter of tubule
length. In addition, Fig. 3 shows that there is a di-
rect relationship between perfusion and absorption
rates of the protein within the range of 1251-labeled
human GH loads tested. The results of all three
studies described above show directly that the
proximal tubule avidly removes protein from tubu-
lar fluid. In addition, the results are consistent with
the conclusions, derived from the renal titration ex-
periments with LZM, that the capacity of the ab-
sorption process is high compared to the estimated
normal filtered loads of the small proteins studied.
The results obtained with small proteins do not
necessarily conflict with the view held by some in-
vestigators that the Tm for albumin is close to the
normal filtered load of this protein [55, 56]. Filtered
loads of albumin (in terms of absolute amount of
protein) are much larger than those of any particular
small proteins or even of all small proteins com-
bined. Therefore, it would not be surprising if the
Tm for albumin is closer to its normal filtered load
than that of LZM, GH, INS, PTH, or other small
proteins. It should be pointed out, however, that
due to uncertainties regarding the precise value of
the albumin concentration in the glomerular filtrate,
reported values for the Tm of albumin are not very
reliable.
The question as to whether the uptake of proteins
by proximal tubular cells is selective remains un-
solved. Unfortunately, lack of adequate experimen-
tal data precludes all but a theoretical discussion of
the subject. If proteins would be absorbed by a non-
specific endocytotic mechanism (that is, simple en-
gulfment of tubular fluid containing the filtered pro-
tein), the tubular uptake of proteins would be a non-
selective process. There is convincing evidence,
however, that filtered proteins bind to the luminal
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Fig. 2. Renal titration of egg-white lysozyme in the isolated perfused rat kidney. Lysozyme was added to the perfusate at the beginning of
the perfusion and then between clearance periods. An equilibration time of 5 to 10 mm was allowed between additions of lysozyme, and
each clearance period lasted 10 to 15 mm, perfusate samples being taken at midpoint. Lysozyme in perfusate (PLY) and urine (ULY) was
measured as in Ref. 6. The results, partially reported before [12, 39] are from experiments in 21 isolated kidneys. Eachpoint represents
one clearance period, except at loads below 200 gImin where several clearance points were combined for illustration purposes.
0.8 is the glomerular sieving coefficient of lysozyme [12, 39]. A Tubular absorption of lysozyme, measured by the difference between
filtered loads and urinary excretion rates of lysozyme (ordinate), is plotted against filtered load of lysozyme (abcissa). B Urinary ex-
cretion rate of lysozyme (ordinate) plotted against filtered loads of lysozyme (abcissa).
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membranes (and/or the cell "coat") before segrega-
tion into endocytotic vesicles takes place [12]. As
shown in Table 2, urine-to-plasma, or urine-to-fil-
trate ratios of LZM, GH, INS, and PTH are always
much lower than those of markers of tubular fluid
reabsorption [11—16]. Therefore, the concentra-
tion of these proteins in endocytotic vesicles must
be greater than their concentration in tubular fluid,
a phenomenon which would only occur if the pro-
tein binds to the luminal membrane or its "coat"
before being incorporated into endocytotic vesicles.
Despite this finding, is it very unlikely that there are
specific receptors at the luminal membrane for each
filtered protein or even group of proteins, which
would provide a basis for their selective reabsorp-
tion. A certain degree of selectivity for uptake could
still take place if the binding to the luminal mem-
brane would be dependent on the charge, or the mo-
lecular size of the protein, or both. The finding that
'311-albumin reabsorption by proximal tubules is
• less than that of 1811-INS or '311-RNAase [54] and
the recent observation that cationic amino acids in-
crease urinary excretion of small proteins [57] pro-
vide some evidence for this hypothesis.
A related and also unresolved question is whether
filtered proteins compete for the absorption pro-
cess. Competition has been postulated on the basis
of experiments that showed either a decrease in ac-
cumulation in renal cells or an increase in urinary
excretion of a protein when filtered load of another
protein is increased [58, 59]. Alternative inter-
pretations, however, are possible. For example, in
our hands [13], high concentrations of myoglobin
led to an increased urinary excretion of LZM, in the
isolated perfused rat kidney, but the phenomenon
was not dose-related, a condition which is essential
to prove competitive inhibition for absorption. The
increased urinary excretion of LZM may have been
the result of damage produced by high concentra-
tions of myoglobin to the glomerular filter, or the
tubular cells, or both. The same explanation could
hold for the other instances in which large concen-
trations of any protein lead to increased urinary
excretion or lack of renal accumulation of other
proteins. The question of selectivity and competi-
tion for tubular uptake of proteins is clearly an
open one, which demands much more investigation
to be answered with confidence.
Tubular uptake of proteins is decreased in a dose-
related manner by metabolic inhibitors such as cy-
anide and iodoacetate [11-16]. Table 2 shows the
effect of high doses of these inhibitors on the frac-
tional clearance of LZM, INS, GH, and PTH in the
isolated perfused rat kidney. At high doses, the in-
hibitors completely block the tubular uptake of pro-
teins, as shown by their negligible accumulation in
kidney tissue (see Fig. 1). As expected, the high
doses of iodoacetate or cyanide also strongly inhibit
the reabsorption of sodium and water by the kidney
[11—16]. Therefore, as previously pointed out [12], it
is not possible to conclude from these experiments
whether the effect of cyanide or iodoacetate on pro-
tein uptake by the kidney is direct or indirect. On
one hand, it is known that iodoacetate or cyanide
markedly affect endocytosis in other cell systems
[60]. On the other hand, it is possible that the de-
crease in tubular uptake of proteins is a secondary
result of the decrease in fluid and electrolyte trans-
port. Evidence was obtained recently that seems to
indicate that protein uptake is a specific process not
directly dependent on net fluid and sodium reab-
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Fig. 3. Tubular absorption of '251-labeled human GH by isolated
proximal convoluted tubules of the rabbit. Proximal convoluted
tubules, dissected and perfused by the method described by Burg
et a! (Am J Physiol 210:1293, 1966) were perfused at 370 C with
ultrafiltrate of rabbit serum to which '4C-inulin and variable
amounts of °51-labeled human GE (New England Nuclear Co.)
were added. Perfusion rates were between 10 and 20 nI/mm. All
perfusion and collecting pipettes were siliconized. Control ex-
periments showed that recovery of '251-labeled human GE from
the pipettes used in the experiments was greater than 90%. TCA-
insoluble radioactivity was measured in perfusion and collection
fluids, and the concentration of labeled TCA-insoluble hormone
was calculated from the specific activity of '251-labeled human
GE. Tubular absorption rates were determined by the difference
between perfused and collected amounts of TCA-insoluble radio-
activity in each perfusion period. Six to eight perfusion periods
were performed in each tubule, each period lasting from 8 to 10
mm. In all experiments, perfusion with the commercial prepara-
tion of 1251-labeled human GE led to an almost complete inhibi-
tion of fluid reabsorption by the proximal tubule. Whether this
effect is due to impurities in the 1251-labeled human GE prepara-
tion or to the hormone itself is unknown. Results shown are from
eight tubules, each point representing one perfusion period. (Fig-
ueiredo and Maack T, unpublished results)
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sorption [61]. Thus, tubular uptake of a small pro-
tein (human GH) in the isolated perfused rat kidney
remained unaffected as net sodium reabsorption
was decreased by as much as 50% by lowering the
oncotic pressure of the perfusate. In addition, and
more importantly, cytochalasin B (a substance
which affects microfilament function and endo-
cytosis in other cell systems) inhibited the tubular
uptake of human GH at doses which did not affect
sodium, potasium, glucose, and water reabsorption
by the isolated kidney. Results of these experiments
with cytochalasin B are illustrated in Fig. 4. There-
fore, these data suggest that specific inhibition of
endocytosis decreases tubular absorption of pro-
teins, without affecting other renal tubular func-
tions.
Results of experiments in isolated perfused tu-
bules of the rabbit indicate that some small filtered
peptides, such an angiotensin and vasopressin, are
hydrolyzed by brush border proteases [62]. It is
doubtful, however, that these proteases are able to
(5) hydrolyze larger peptide-hormones such as PTH,
INS, GH or other small proteins to any important
extent. Indeed, inhibition of tubular absorption of
labeled proteins by cyanide or iodoacetate leads to
urinary excretion of TCA-insoluble radioactivity
[11—16]. Because it is unlikely that these inhibitors
affect brush border enzymes, this finding suggests
that luminal proteases are unable to hydrolyze the
protein to small fragments. Furthermore, combined
autoradiographic and gel chromatographic studies
with LZM and GH indicate that labeled proteins
and not their labeled catabolites accumulate in renal
cells, a result opposite to that expected if the pro-
tein had been extensively hydrolyzed by brush bor-
der proteases [10, 15]. Finally, even in the case of
PTH where catabolites rather than intact protein
are present in the cell at very early times after ad-
ministration of 1251-labeled bovine PTH, the evi-
dence favors intracellular rather than brush border
hydrolysis [16]. Despite this evidence, it cannot be
completely ruled out that brush border proteases
can modify the filtered proteins before their uptake
into the renal cells.
Under normal conditions, only minimal amounts
of small proteins are detected in urine. The studies
described above show that this is due to extensive
tubular absorption rather than to any sizeable hin-
drance to the passage of circulating small proteins
into the glomerular filtrate.
Results of quantitative studies on the filtration
and absorption of small proteins by several investi-
gators have also provided the basis for an under-
standing of the pathophysiology of low-mol-wt pro-
teinuria [11, 12, 38, 44, 63—70]. A brief summary of
their conclusions follows. Increased urinary excre-
tion of low-mol-wt proteins is primarily the result of
either an increase in plasma concentration or a de-
crease in tubular absorption of small proteins. The
former is observed in conditions in which there is an
overproduction (or increased release to plasma) of
specific small proteins, such as in multiple myeloma
(Bence Jones proteins), mono- and myelomonocytic
leukemias (lysozyme), and several other conditions
too numerous to cite here. It should be emphasized
that even small increments in plasma levels of small
proteins may result in a significant urinary excre-
tion, because, as pointed out above, a direct rela-
tionship between plasma concentration and urinary
excretion of a small protein may be found at filtered
loads below saturation of the absorption process.
The other major condition for low-mol-wt protein-
uria is impairment of tubular uptake of proteins by
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Fig. 4. Effect of cytochalasin B on the tubular absorption of 525J
labeled human GH by the isolated perfused rat kidney. 125I-hu-
man GH was added to the perfusate at the beginning of the per-
fusion, and two to three control clearance periods were per-
formed. Then, cytochalasin B was added to the perfusate in the
indicated concentrations, and after an equilibration period of 10
to 15 mm, two to three additional clearance periods were per-
formed. Tubular absorption of 1251-human GH was calculated as
in Refs. 13, 15. Results are expressed as percent inhibition of 125J..
human GH absorption, relative to control periods. Mean and
SEM values for each dose are indicated in the figure. At the lower
doses of cytochalasin B (2.5 and 5.0 sg/ml), the drug had minimal
or no effect on GFR, sodium, water, or glucose reabsorption. At
the highest dose these parameters were significantly depressed.
(Data from Ref. 60)
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tubular lesions, such as occurs in Fanconi syn-
drome, Wilson's syndrome, or chronic cadmium
poisoning. Excretion of small proteins in these con-
ditions is massive, up to 10,000-fold greater than in
normal conditions. This is to be contrasted with the
modest increase in urinary excretion of small pro-
teins in lesions that affect primarily the glomerulus.
The opposite relationship is found for larger pro-
teins such as albumin, that is, modest albuminuria
in primarily tubular lesions and massive albumin-
una in primarily glomerular lesions. The contrast be-
tween the urinary excretion of small and large pro-
teins in primarily glomerular, as opposed to primari-
ly tubular, proteinurias is due on one hand to the
differing glomerular permeabilities to these two
groups and on the other hand, to the characteristics
of the tubular absorption process of proteins. In pri-
marily glomerular lesions, increases in glomerular
permselectivity, and hence filtered loads of small
proteins, is modest, because the glomerular sieving
coefficient of these proteins is normally high. If
tubular absorption is not impaired, part of the in-
creased load of small proteins will be absorbed.
Hence, any increase in urinary excretion will be
minimized. That urinary excretion does increase at
all in primarily glomerular nephropathies may be
due to the generally low affinity of the tubular ab-
sorption process rather than to Tm'S which are close
to the normal filtered load. With larger proteins
such as albumin, small changes in glomerular per-
meability will lead to large increases in filtered load.
If the Tm of albumin is close to the normal filtered
load, as postulated by some authors, the excess
load will be entirely excreted into the urine. Even if
the Tm of albumin is much larger than the normal
filtered load, however, an increase in glomerular
permeability will lead to massive albuminuria due to
the low affinity of the absorption process. In primar-
ily tubular nephropathies, on the other hand, the
predominantly low-mol-wt proteinuria is due to im-
pairment of tubular uptake of the normal propor-
tionally high filtered loads of small proteins. Al-
buminuria will be less prominent than in glomerular
nephropathies because of the proportionately lower
filtered loads of albumin. The terms high- and low-
molecular-weight proteinuria should be used, how-
ever, as relative terms, because, due to the very
high plasma concentration of albumin compared to
that of small proteins, albumin may still account for
a large fraction of the total protein excretion in low-
mol-wt proteinurias.
A rather unique aspect of the handling of small
proteins by the kidney is that under normal condi-
tions removal of filtered proteins from the circula-
tion is accomplished mainly by tubular absorption
and only minimally by urinary excretion. When
tubular absorption is inhibited and urinary excre-
tion correspondingly increased, however, the rate
of removal of small proteins from plasma does not
change significantly. Therefore, tubular absorption
is not a rate-limiting process for the removal of
small proteins from the circulation. This was first
discovered in experiments which compared the
plasma disappearance rate of Bence Jones proteins
in normal mice and in mice in which tubular absorp-
tion was blocked by maleate [70]. Despite the large
increase in urinary excretion in the latter condition,
the plasma disappearance rate of Bence Jones pro-
tein was the same in both groups of animals. It thus
became clear that absorbed Bence Jones protein
must be catabolized by the renal tissue. The quan-
titative aspects of the renal catabolism of absorbed
proteins will be considered next.
IV. Renal catabolism of small proteins
The rate of catabolism of an absorbed protein can
be roughly determined by measuring its rate of dis-
appearance from the tissue (intact kidney, kidney
slices, or isolated perfused rat kidney) after the kid-
neys are preloaded with the protein in vivo or in
vitro [7, 11—17, 28, 58, 71]. Figure 5 gives an ex-
ample of the disposal of administered 1251-labeled
human GH from the intact rat kidney and from an
isolated perfused rat kidney. Figure 5A shows that
from 10 to 20 mm after the administration of 125J
labeled human GH, the concentration of radio-
activity in kidney is maximal at a time when plasma
concentration of TCA-insoluble radioactivity is al-
ready very low. Figure 5B, a chromatograph of kid-
ney homogenate shows that the radioactivity ac-
cumulated in kidney tissue was eluted together
with the labeled hormone; that is, absorbed 125k
labeled human GH, and not a catabolite of the
protein, was present in kidney tissue 20 mm after
administration of the hormone. During the next 20
mm about 50 to 60% of the radioactivity disappeared
from the kidney. Figure SC shows the effiux of
radioactivity from an isolated perfused rat kidney
which had been preloaded with '251-labeled human
GH in vivo. There is surprisingly good agreement
between the rate of effiux of radioactivity from
the perfused kidney (about 50% of the radioactivity
initially present in the kidney was released to the
perfusate in about 30 mm) and the rate of decrease
of radioactivity from the kidney of the intact rat
shown in Fig. 5A. Figure 5D, a chromatograph of the
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perfusate at the end of the experiment, shows
that almost all of the radioactivity released to the
perfusate is attached to a catabolite, 1251-mono-
iodotyrosine. This finding, coupled with those
from similar experiments with radioiodinated rat
GH, bovine PTH, and egg-white LZM led to the
conclusion that absorbed proteins are catabolized
within the renal cells and that the products of catab-
olism are returned to the circulation [11, 16]. Efflux
of radioactivity from kidney slices obtained from
kidneys preloaded in vivo with radioiodinated egg-
white LZM and cytochrome C gave results similar
to those obtained in the isolated perfused rat kidney
[28, 71]. The rate of catabolism of different proteins
varied considerably, being of the order of minutes
for most peptide-hormones. Among them, 1251-la-
beled bovine PTH was the fastest (half-life in kid-
ney tissue of less than 10 mm [16]). For some en-
zymes the rate of hydrolysis is much slower, for ex-
ample, absorbed egg-white LZM or rat LZM
remains in kidney tissue for many hours [6, 9, 10-
12], and horseradish peroxidase, for a few days
[22]. More indirect evidence suggests that the rate
of hydrolysis [72, 73] of light chains of immunoglob-
ulins is also rather slow.
Regarding the products of hydrolysis of absorbed
small proteins, the information available is rather
limited. Because radioiodinated proteins were used
in the type of experiments described above, only
catabolites containing tyrosine could be detected.
In the experiments with radioiodinated rat GH, hu-
man GH, LZM, and cytochrome C, in which break-
down by kidney deiodinases was obviated by the
use of an excess of unlabeled monoiodotyrosine,
the only detectable product of catabolism of these
proteins was 1251-monoiodotyrosine [12, 15, 28, 71].
In similar experiments with 1251-labeled bovine
PTH, an unidentified labeled catabolite was detect-
ed in the effluent of perfused rat kidneys. This un-
identified product, however, may have been diiodo-
tyrosine rather than a peptide containing tyrosine
[16]. Since tyrosine is located in different positions
within the molecules of the proteins tested, these
data suggest that the catabolism of absorbed small
proteins goes to completion, that is, the resulting
catabolites are single amino-acids rather than pep-
tides. It cannot be completely ruled out, however,
that some small peptides originate from the intra-
cellular hydrolysis of absorbed proteins and are re-
turned to the circulation. In experiments with iso-
lated perfused rat kidneys preloaded with unlabeled
and labeled egg-white LZM, part of the absorbed
protein was released intact back to the perfusate
[12], confirming previous observations with this
protein in flounder renal tubules [7]. Efflux experi-
ments, however, in kidney slices from rats kidneys
preloaded with '251-labeled egg-white LZM failed to
detect the release of intact '251-LZM from kidney
tissue [28]. Differences in the degree of iodination
and dose of administered LZM may explain the dis-
crepancy between these results. In our view, re-
lease of intact, absorbed LZM back to the perfusate
does occur, at least in some conditions. In our ex-
periments, it may have been the result of a large
accumulation of this slowly hydrolyzable protein
within lysosomes. This can lead to a disruption of
lysosomal membranes, spillage of the protein to-
gether with lysosomal enzymes to the cytosol [10],
and the eventual release of a part of the absorbed
LZM to the perfusate. In addition, presence of ab-
sorbed LZM in renal tissue leads to a marked in-
crease in the activity of some lysosomal enzymes
[6]. This phenomenon may occur in those pathologic
conditions where plasma levels of lysozyme (or
other poorly hydrolyzable proteins, such as some of
the light chains of immunoglobulins) are markedly
elevated, as in monocytic leukemias or multiple
myeloma. Contrary to the implications in our early
studies with LZM [7, 10], however, release of intact
absorbed proteins to the circulation is probably not
the physiologic mode by which the kidney handles
most filtered proteins [12, 15, 16].
The physiologic significance of the process of re-
moval of small proteins from the circulation by re-
nal catabolism rather than urinary excretion is un-
known. As first pointed out in studies with light
chains of immunoglobulins [44, 70], the rate of re-
moval from plasma is the same regardless of wheth-
er the small proteins are absorbed and catabolized
or are excreted in the urine (see last paragraph of
section III). It could be argued that since the amino
acids resulting from the intracellular catabolism of
absorbed proteins are released back to the circula-
tion, the organism conserves substances which are
not important for the body economy. The amount of
amino acids generated by the renal catabolism of small
proteins, however, is insignificant compared to the to-
tal body pool of amino acids. A more provocative
speculation is that the catabolic products resulting
from the renal hydrolysis of a protein may exert some
feedback control over the production or release of
this protein to the circulation. Clear experimental
evidence for this hypothesis, however, is lacking.
Partial hydrolysis of small proteins by the kidney
has been reported only for PTH. Studies in the iso-
lated perfused dog kidney show that intact immuno-
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reactive bovine PTH (1-84 bovine PTH; mol wt,
9,000 daltons) is hydrolyzed to a 7,000-dalton frag-
ment, which is said to be biologically inactive, and
possibly to a 3,500-dalton fragment (bovine PTH 1-
34), which is biologically active [74]. Apparently,
this partial hydrolysis takes place at the peritubular
side, but the 7,000-dalton fragment can only be dis-
posed of by the kidney via a filtration-absorption
route [75]. This observation may explain the finding
of increased plasma levels of the 7,000-dalton PTH
fragment in renal failure [74, 75]. Since PTH has its
renal receptors at the peritubular membranes, it is
not surprising that this protein may be partially hy-
drolyzed at peritubular sites. The partial hydrolysis
of INS at peritubular sites could also explain the
finding that the renal extraction of immunoreactive
INS is greater than can be accounted for by filtra-
tion alone [76]. Whether other small circulating pro-
teins can also be partially hydrolyzed via the pen-
tubular route remains to be determined. In any
event, the data obtained so far indicate that even if
partial peritubular hydrolysis occurs, the final renal
catabolism of a circulating protein takes place via
the filtration-absorption route.
The renal catabolism of an absorbed protein is
not rate-limiting for its plasma disappearance, ex-
cept perhaps for proteins which are hydrolyzed
very slowly by lysosomal enzymes. Indeed, if an
absorbed protein cannot be returned intact to the
circulation, it will eventually be hydrolyzed within
the renal cells. In steady-state conditions, the rate
of hydrolysis must be equal to the rate of tubular
absorption; otherwise there would be an infinite in-
crement in the renal accumulation of this protein.
Therefore, the rate of hydrolysis cannot be limiting
for the plasma disappearance of a small protein.
The rate of intracellular digestion, however, will de-
termine in part the steady-state concentration of a
small absorbed protein in kidney tissue. Indeed, the
slower the catabolic rate, as compared to the ab-
sorption rate, the larger must be the steady-state
concentration of the protein in kidney tissue to per-
mit a balance between cell uptake and intracellular
hydrolysis of the protein. The physiologic con-
sequence of this phenomenon is unknown. The pre-
dicted inverse relationship between renal catabolic
rate and renal accumulation of filtered protein, how-
ever, explains the presence of protein-absorption
droplets when protein filtered loads are increased
either by an increase in glomerular permeability (for
example, albumin in the nephrotic syndrome) or by
an increase in plasma concentration of small, poorly
hydrolyzable proteins (for example, lysozyme in
monocytic leukemias, Bence Jones proteins in mul-
tiple myeloma). Eventually, the high concentration
of these proteins in renal cells may cause tubular
damage and further deterioration of renal function
[73, 77].
V. Role of the kidney in the overall plasma turnover of
small proteins: Extent and pathways of renal extraction
of small proteins
The finding that the kidney filters, absorbs, and
catabolizes circulating proteins does not by itself
define the role of this organ in the plasma turnover
of small proteins. The degree to which the kidney
contributes to this phenomenon was inferred initial-
ly from results of experiments comparing plasma
levels and/or plasma half-lives of endogenous or ad-
ministered proteins in intact and anephric experi-
mental animals or humans. For all small proteins
tested to the present, plasma level, or plasma half-
life, or both were markedly increased in bilaterally
nephrectomized animals, humans or in renal failure.
The pioneer work in this regard was the study com-
paring endogenous serum ribonuclease activity in
control dogs and in dogs which had undergone bilat-
eral nephrectomy or a ureteral-venous anastomosis
[78]. It was then shown that serum RNAase activity
increased markedly after bilateral nephrectomy, in
direct proportion to the increase in serum creatinine
concentrations. When the urine was returned to the
circulation via the ureteral-venous anastomosis,
however, serum RNAase activity remained close to
normal, whereas serum creatinine concentration
rose as in the bilaterally nephrectomized dogs. These
results led to the conclusion that the kidney macti-
yates serum RNAase. Since this study, other inves-
tigators using a similar approach found that the kid-
ney also inactivates endogenous LZM activity or
GLU immunoreactivity [9, 79]. In addition to these
findings, numerous studies have revealed that in
nephrectomized animals there is an increase in
plasma level andlor plasma half-life of a host of en-
dogenous circulating small proteins, including
RNAase, LZM, INS, GH, GLU, PTH, 132 micro-
globulin, Bence Jones proteins, and fragments of
immunoglobulins [9, 43—45, 70, 72, 76, 79—91]. The
results of all these experiments indicate that the kid-
neys play an important role in the disposal of circu-
lating small proteins, but they do not permit a pre-
cise estimate of the extent of this phenomenon.
An increase in plasma levels of proteins in nephrec-
tomized animals or humans may be partly due to
an increase in production rather than a decrease
in renal catabolism, as is certainly the case with
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PTH and possibly also with LZM [82, 93]. Mea-
surements of plasma disappearance rate in the
presence and absence of the kidneys may circum-
vent the above problem but may introduce other ar-
tifacts. Thus, on one hand, in the absence of the
kidneys other organs may compensate partially or
totally for the lack of renal catabolism of the pro-
tein. On the other hand, changes in body fluid com-
partments or other secondary events associated
with bilateral nephrectomy may lead to a decrease
in the rate of removal of small proteins by other or-
gans. In the former case, the role of the kidney in
the determination of the plasma turnover of a pro-
tein would be underestimated, while in the latter
case it would be overestimated.
The renal turnover of a protein can be precisely
measured by determining its absolute renal extrac-
tion rate. In intact animals, this parameter is mea-
sured by the product of the renal arteriovenous con-
centration difference of the protein and the renal
plasma flow. The fractional renal turnover rate is
defined as the ratio of the renal turnover to the total
plasma turnover of the protein. The latter is taken
as the plasma disappearance rate (metabolic clear-
ance rate) of the protein. Theoretically, the frac-
tional renal turnover rate of a protein defines ex-
actly the degree to which the kidney contributes to
the overall plasma turnover of that protein. In prac-
tice, several limitations are to be considered. First,
if the renal arteriovenous concentration difference
of a protein is small, the error of measuring its renal
turnover rate becomes very large because of the
normally high renal plasma flow. Second, plasma
protein decay curves are multiexponential and thus
difficult to analyze in detail. Third, and most impor-
tant, the interpretation of the particular measure-
ment of a protein is not always clear. Thus, proteins
may be determined by enzymatic, immunologic, or
biologic assays, which measure properties of only a
portion of the protein molecule. Therefore, on one
hand, a protein may be considerably modified by
the kidney and still retain its enzymatic, immuno-
logic, or biologic activity. On the other hand, it may
be only slightly altered and yet may lose one or
more of these properties. A case in point is the het-
erogeneity of circulating PTH [74, 75, 92, 93]. Dif-
ferent molecular forms of the hormone, the intact
active form and a large inactive fragment, probably
formed by partial hydrolysis of intact PTH in the
kidney react similarly to some antibodies. In addi-
tion, two biologically active forms (1-84 and 1-34
PTH) cannot be discriminated by some antibodies.
GLU is another example of a hormone circulating in
plasma in different molecular forms—a 3,500-dal-
ton and a 9,500-dalton peptide [79]. As more specif-
ic antibodies against portions of the protein mole-
cules are developed and as plasma fractionation
procedures improve, many peptide hormones,
thought initially to be homogeneous, become in
reality a heterogeneous group of molecules. There-
fore, to measure the renal extraction of a protein, it
is necessary in principle to characterize the mole-
cule fully both in renal arterial and in renal venous
blood. Labeling of the protein molecule circum-
vents some of the difficulties described above but
may introduce other artifacts, such as denaturation,
polymerization, or inactivation of biologic activity
of the protein. Despite the problems mentioned
above, there is consensus among investigators in
the field that the kidney accounts for a major, if not
the major, fraction of the overall plasma turnover of
several circulating enzymes, immunoproteins, and
peptide hormones. Experimental measurement of
the fractional turnover rate in either intact animals
or the isolated perfused rat kidney of several small
proteins, including INS, C-peptide, proinsulin,
GLU, PTH, GH, LZM, shows that 40 to 80% of
their total plasma turnover can be attributed to re-
nal catabolism [9, 15, 16, 42, 43, 76, 79]. These ex-
periments were done with labeled or unlabeled and
homologous or heterologous proteins. Thus, there
is little doubt that the kidney is a central organ for
the disposal of circulating small proteins.
The findings that the glomerular sieving coeffi-
cient of small proteins is generally high and that
transtubular transport of intact protein does not oc-
cur for most proteins suggest that the filtration route
is of primary importance for the renal extraction of
small proteins. In addition, the absence of an endo-
cytotic apparatus on the contraluminal side of tubu-
lar cells and the lack of evidence that circulating
proteins are taken up into the cell from the con-
traluminal side suggest that renal extraction by pen-
tubular uptake of proteins into the cell does not oc-
cur. As already pointed out, these data do not ex-
clude the possibility that proteins may be inactivated
or modified by interactions at the peritubular side,
particularly if there are specific receptors for a pro-
tein on the basal cell membrane. The strongest evi-
dence indicating the existence of a peritubular route
for extraction of proteins comes from experiments
with immunoreactive insulin. In several experi-
ments in rats, dogs and humans, it was found that
the renal extraction rate of this protein was larger
than could be accounted for by filtration alone [76,
91, 94, 95]. Therefore, immunoreactive insulin must
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have been removed from the renal circulation
from the peritubular side in addition to its removal
by filtration. There is, however, excellent evi-
dence that at least labeled insulin is not absorbed
into the cell from the peritubular side [27]. In
addition, lymph flow in the kidney is too small to
account for peritubular removal of insulin via the
lymphatic route. Therefore, it is likely that pro-
teases located at the peritubular side of the renal
cells are able to at least modify the immuno-
reactivity of the INS molecule. For most proteins,
however, renal extraction is less than the GFR, and
thus there is no need to postulate the presence of a
peritubular mechanism to inactivate circulating pro-
teins. Peritubular extraction of several small pro-
teins has been postulated, however, on the basis of
experiments showing persistence of renal extrac-
tion in ureter-ligated animals [71, 75, 76, 79]. In
these experiments, significant renal extraction or
decrease in plasma disappearance rates which were
less than those observed in nephrectomized animals
were taken as evidence for peritubular extraction of
the proteins studied. Fluid filtration rate, however,
can still be considerable when ureters are acutely
ligated. In addition, a considerable amount of pro-
tein can diffuse into the filtrate when GFR is very
low. Therefore, it becomes difficult to quantitate the
residual extraction of protein by filtration in ureter-
ligated animals (see Ref. 89). Recently, a new ex-
perimental approach was devised to measure with
more certainty the contribution of the peritubular
side to the renal extraction of a protein [15, 16]. The
method consists of measuring the renal extraction
of a protein in an isolated perfused rat kidney in
which filtration is abolished by raising the oncotic
pressure of the perfusate sufficiently to counterbal-
ance filtration forces. In this manner, renal per-
fusate flow and hence the delivery of the protein to
the peritubular side is kept at the same levels as in
the filtering isolated kidney. The integrity of normal
peritubular uptake processes is maintained, as
shown by the finding that accumulation of organic
acids in the nonfiltering kidney does not differ sig-
nificantly from that in the filtering kidney [31].
Renal extraction of proteins in both the filtering and
nonfiltering isolated perfused rat kidneys can be
easily measured by determining the perfusate dis-
appearance rate of the protein [15, 16]. With this
approach, it was found that peritubular extraction
of homologous 1251-labeled rat GH and heterologous
1251-labeled bovine PTH was negligible compared to
their extraction by filtration. In addition, it was
found that extraction by filtration accounted for
more than 60% of the plasma disappearance of the
labeled hormones in the intact rat [15, 16]. The 1251..
labeled rat GH used in these experiments remained
intact as far as could be assessed by radioimmuno-
assay and radioreceptor assay, and had the same
plasma disappearance rate as unlabeled rat Gil.
The '251-labeled bovine PTH used, in addition to
being heterologous, however, was probably ren-
dered biologically inactive by the labeling proce-
dure. It is noteworthy, however, that the fractional
renal turnover of 1251-labeled bovine PTH was
similar to that determined for immunoreactive
bovine PTH in the dog [16, 42]. The evidence ob-
tained with GH and PTH in the isolated perfused
rat kidney experiments does not rule out the possi-
bility that these hormones are modified at peritubu-
lar sites, a modification which may be important for
their biologic activity, as proposed for PTH [75].
It does prove, however, that the final extraction
occurs essentially by a process of ifitration and tubu-
lar uptake of the hormones. It should be emphasized
that renal extraction by filtration is independent of
the biologic activity of the protein and takes place
whether or not the kidney is a target organ for a
particular small protein. As previously pointed out
[16], the nonspecificity of this process should not
be taken to indicate that the renal extraction of small
proteins by filtration does not have a biologic func-
tion or a homeostatic value. Essentially what this
renal process accomplishes is the maintenance of
adequate plasma levels of small proteins, because,
under normal conditions, the renal turnover rate of
a particular small protein is directly proportional to
its plasma concentration. In this sense, the renal
handling of small proteins is just one more aspect of
the primary function of the kidney in mammals, the
maintenance of balance in the internal environment.
Summary
Circulating small proteins are extensively filtered
by the kidney. Included among these proteins are
important peptide-hormones (for example, INS,
GLU, PTH, Gil), enzymes (for example, LZM,
RNAase), and immunoproteins (for example, /32 mi-
croglobulin, light chains of immunoglobulins). The
glomerular sieving coefficient of circulating pro-
teins, smaller than 20,000 daltons, is greater than
0.5, leading to filtered loads which are many fold
larger than the plasma pool of these proteins.
Filtered proteins are extensively absorbed by the
tubular epithelium, minimal amounts appearing in
the urine. The tubular uptake process is character-
ized by a high capacity as compared to the normal
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filtered loads of small proteins; it is directly or in-
directly dependent on energy input, and it is inhib-
ited by cytochalasin B, a substance which interferes
with endocytosis in other cell systems. The mecha-
nism of uptake can be best described as a specific
endocytotic process because it depends on the bind-
ing of the protein to brush border membranes be-
fore the protein is incorporated into the endocytotic
vesicles. The characteristics and extent of tubular
absorption of small proteins explains the massive
urinary excretion of small proteins when their
plasma levels are elevated or when the tubules are
damaged.
Absorbed proteins are hydrolyzed to amino acids
within the renal cells, and these catabolic products
are then returned to the circulation. The rate of hy-
drolysis depends on the nature of the protein, being
of th order of minutes for most peptide hormones
and many hours or days for enzymes and foreign
proteins. The differences between the rate of renal
catabolism among absorbed proteins is probably re-
lated to their degree of resistance to lysosomal acid
hydrolases. Increased filtered loads of poorly hy-
drolyzable protein cause their accumulation in renal
cells as "absorption droplets." This accumulation
may lead to tubular damage and consequently to an
increase in the urinary excretion of several low-mo-
lecular-weight proteins.
Although final catabolism of a circulating small
protein occurs via filtration and tubular uptake from
the luminal side, partial hydrolysis of some small
proteins may take place at peritubular sites. This
phenomenon may be of importance for the activa-
tion or inactivation of peptide hormones such as
INS, PTH and GLU, but the physiologic role of this
process is still unknown.
The kidney plays a major role in the disposal of
several circulating small proteins, with renal extrac-
tion accounting for 30 to 80% of their plasma dis-
appearance rates (metabolic clearance rate). The
rate-limiting step for the removal of small proteins
from the circulation is the rate by which these pro-
teins are filtered by the kidney. The process of fil-
tration of small proteins is obligatory in nature and
homeostatic in result; obligatory in the sense that it
does not depend on the biologic function of the pro-
tein but on the physical characteristics of the mole-
cule (size, symmetry, charge, binding to larger
molecules) and of the glomerular filter (GFR, perm-
selectivity). The process of filtration is homeostatic
in result because filtered loads—hence, renal cata-
bolic, or urinary excretion rates, or both—are di-
rectly proportional to the plasma concentrations of
small proteins. The increase in plasma concentra-
tions of several small proteins in acute renal failure
illustrates well the importance of the process of fil-
tration for the disposal of circulating small proteins.
The abnormal plasma levels of small proteins in
conditions of marked decrease in GFR may contrib-
ute importantly to several of the symptoms ob-
served in uremic patients.
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